Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol proteinases, also known as cysteine proteases, are a class of proteolytic enzymes that utilize a cysteine residue in their active site to catalyze the hydrolysis of peptide bonds in proteins. They are found across all domains of life and serve diverse physiological roles, including protein catabolism, apoptosis, immune responses, and pathogen virulence. Overexpression or dysregulation is linked with diseases such as cancer metastasis and inflammatory conditions. They are also targets for drug development against parasites and have been explored as vaccine candidates.
Inhibition of cysteine protease activity through covalent or non-covalent binding to the active site cysteine residue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol Proteinase.